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Background: Obesity is associated with an elevated risk for several types of cancer and thus a major health hazard.
However, the mechanism between overweight and cancer susceptibility is still elusive. Leptin, mainly produced by
adipocytes links food intake and energy expenditure. In addition, recent studies have shown an immunomodulatory
impact of leptin on NK cells. The purpose of the present study was to investigate whether leptin stimulation of NK
cells from obese humans leads to altered functions as compared to NK cells from lean subjects. On the basis of
body mass index 20 healthy individuals were classified in two groups: normal weight (<25 kg/m2) and obese
(>30 kg/m2). Peripheral blood mononuclear cells (PBMC) were isolated from blood samples. We used flow
cytometry to assess differences in phenotype and activity markers (CD107a, CD178 and TRAIL) of PBMCs between
both groups. Furthermore, we determined after short-term in vitro leptin stimulation the phosphorylation of JAK2,
downstream target of the intracellular signaling cascade of the leptin receptor, by Western Blotting and numbers of
NK-cell-tumor-cell-conjugates as well as Granzyme+ and IFN-γ+ NK cells by flow cytometry. Finally, the proliferative
capacity of control and long-term (7 days) leptin-stimulated NK cells was examined.
Results: As opposed to similar NK cell counts, the number of CD3+CD56+ cells was significantly lower in obese
compared to lean subjects. Human NK cells express the leptin receptor (Ob-R). For further determination of Ob-R,
intracellular target proteins of PBMCs were investigated by Western Blotting. Phosphorylation of JAK2 was lower in
obese as compared to normal weight subjects. Furthermore, significantly lower levels of TNF-related apoptosis-
inducing ligand (TRAIL) as an NK cell functional marker in obese subjects were found. In vitro leptin stimulation
resulted in a higher production of interferon-γ in NK cells of normal weight subjects. Interestingly, long-term leptin
stimulation had no significant influence on numbers of proliferating NK cells.
Conclusions: NK cells from obese healthy humans show functional deficits and altered responses after in vitro
leptin challenge.
Keywords: Obesity, Immunity, Natural killer (NK) cells, Leptin, Ob-R, TRAIL, CD107aBackground
Obesity is a major health hazard manifested by its rap-
idly increasing prevalence [1]. Beside a reduced life ex-
pectancy, obesity is associated with an elevated risk for
certain diseases like cardiovascular disease and type 2
diabetes [2] as well as severe inflammations [3]. Further-
more, obese individuals have a higher risk for several
types of cancer, e.g. oesophageal adenocarcinoma, post-
menopausal breast cancer and colon cancer [4,5]. Several
mechanisms behind the link between an increased body-
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unless otherwise stated.the insulin-IGF (insulin-like growth factor) axis [6,7], in-
creased bioavailability of steroid hormones [8] and adi-
pose tissue-derived hormones and cytokines (adipokines)
[9,10].
One of these adipocyte-derived hormones is the 16-
kDa leptin [11], mainly produced by the white adipose
tissue. The serum levels of leptin the product of the
obese (ob) gene, correlate with body weight and is
higher in obese individuals [12]. There are at least six
alternatively spliced isoforms of the leptin receptor
(Ob-Ra – Ob-Rf ). Beside Ob-Re, the soluble form, all
leptin-receptors share an intracellular binding site for
the receptor-associated Janus-family tyrosine kinase-
(JAK) 2. However, only the long-form, Ob-Rb, is capable
in mediating all leptin actions [13]. Upon ligand bindinghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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motes the phosphorylation of three tyrosine residues
(Tyr985, Tyr1077 and Tyr1138) on the intracellular do-
main of Ob-Rb for distinct signaling pathways [14]. Via
JAK2 phosphorylated Tyr1183 recruits the signal trans-
ducer and activator of transcription (STAT) 3 for the
JAK/STAT-pathway. Activated STAT3 translocates to
the nucleus for the regulation of gene expression.
Ob-R, product of the db (diabetes) gene, is localized in
several tissues mediating transport and degradation of
leptin but only the long-form is highly expressed in the
hypothalamus [15]. Moreover, leptin-receptor-deficient
(db/db) mice share an abnormally spliced leptin-receptor
resulting in a phenotype of severely obese animals [16].
Accordingly, leptin links the nutritional status by acting in
hypothalamic nuclei and regulating food intake and en-
ergy expenditure [17].
However, in the last years it becomes evident that lep-
tin also affects both the adaptive and the innate immune
system [18,19]. Natural killer (NK) cells belong with their
abilities in production of cytokines, such as interferon-γ
(IFN-γ), and cytotoxicity against transformed as well as in-
fected cells to the innate immunity. Beside a variety of ac-
tivating and inhibitory receptors, NK cells express Ob-R
and have increased cytotoxicity after leptin stimulation
in vitro [20]. However, a recent study of our group showed
diminished immune functions after long-term leptin ex-
posure of human NK cells [21]. Db/db mice have an im-
paired NK cell activity suggesting leptin as necessary for
the development and activation of NK cells [22]. An 11-
year-follow-up study indicated that low cytotoxic activity
of peripheral-blood lymphocytes is associated with in-
creased cancer susceptibility [23]. Our group demon-
strated attenuated NK cell activity in diet-induced obese
rats after leptin administration caused through abrogated
post-receptor signaling of the JAK/STAT-pathway [24].
However, only few data exist describing the activity of NK
cells in obese compared to normal weight humans. In the
present study, we observed lower activity of NK cells as
well as significantly lower levels of components of the
Ob-R signaling pathway in obese healthy humans. Fur-
thermore, NK cells in obese showed a non-significant
altered proliferation process suggesting leptin as a pos-
sible link between bodyweight, lower NK cell functio-




The study was approved by the ethics committee of the
Hannover Medical School, Hannover, Germany. Informed
consent has been received from 20 healthy subjects. All
subjects’ data were determined by self-report and mea-
sured with a standardized questionnaire. Exclusion criteriawere an age < 18 or > 65 years, an acute infection, im-
munosuppression or known cancer in anamnesis. On
the basis of body mass index (BMI; kg/m2) the study sub-
jects were classified in two groups: obese with BMI >
30 kg/m2 (3 females and 9 males) and normal weight with
BMI < 25 kg/m2 (4 females and 4 males). All obese sub-
jects were patients in the sleep laboratory of Hannover
Medical School for medical examination of sleep apnea
syndrome.Isolation of human peripheral blood mononuclear cells
(PBMC) from human subjects and measurement of
triglyceride, cholesterol and glucose
Blood samples were taken from the study subjects be-
tween 8 a.m. and 10 a.m. and immediately heparinized.
A small sample from 10 subjects (normal weight: 5;
obese: 5) was used to measure levels of triglyceride,
cholesterol and glucose via photometry by P800 module
of Roche MODULAR PPE (Roche and Hitachi, Japan).
Furthermore, the blood was diluted with phosphate buff-
ered saline (PBS) and the peripheral blood mononuclear
cells (PBMC) were isolated from cell suspension by
Ficoll gradient (Biocoll, Biochrom, Berlin, Germany) and
collected from the interphase.Reagents
Recombinant human leptin was obtained from R&D Sys-
tems (Wiesbaden, Germany) and diluted to 50 nM.Flow cytometry
For phenotypic analyses PBMCs were stained with the
directly labelled monoclonal mouse-anti human anti-
bodies CD3 conjugated with phycoerythrin (PE)-Cy7
(CD3-PE-Cy7) (clone SK7, 1:50), CD56 conjugated with
allophycocyanin (CD56-APC) (clone NCAM16.2, 1:100),
anti-hLeptin R (Ob-R) conjugated with carboxyfluo-
rescein (anti-hLeptin R-CFS) (clone 52263, 1:20) (R&D
Systems, Wiesbaden, Germany), CD253-PE (TRAIL;
clone RIK-2, 1:20) (BD Biosciences, San Diego, CA),
CD107a conjugated with FITC (clone H4A3, 1:10) (BD
Biosciences), and biotinylated CD178 (clone NOK-1,
1:10) (BD Biosciences) followed by labeling with PerCP-
Cy5.5-conjugated streptavidin (1:500) (BD Pharmingen,
Heidelberg, Germany). PBMCs (5 × 105 cells/100 μl) were
incubated in 96 well-round bottom plates with the
above mentioned antibodies for 20 min at 4°C, washed
twice with measuring buffer and analyzed by flow cy-
tometry using a FACSCanto (BD Biosciences, San Jose,
CA) with FACS Diva software v5.0.3. A well with cells
stained with the above mentioned antibodies except for
anti-hLeptin R-CFS served as control for the measure-
ments of Leptin R.
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After 24 h of cell culture and stimulation with leptin
(50nM; R&D Systems) the expression of intracellular cy-
tokines by NK cells was analyzed using a FACSCanto
cytometer. Prior to intracellular labelling cell surface
staining was performed. PBMCs (5 × 105 cells/100 μl in
96-well round-bottom plates) were stained with CD3-PE
(1:250) and CD56-APC (1:100). After 15 min at 4°C,
cells were washed twice with measuring buffer and in-
cubated with PBS supplemented with 4% paraformal-
dehyde (Merck, Darmstadt, Germany) in the dark for
10 min at room temperature. Cells were washed twice
with measuring buffer and centrifuged for 3 min at
400 g. Thereafter cells were washed once with saponin
buffer (aqua dest. supplemented with 0.1% saponin and
0.01 M HEPES), then resuspended in saponin buffer and
stained with the directly labelled mononuclear mouse
anti-human antibodies granzyme A (GzmA) conjuga-
ted with fluorescein isothiocyanate (GzmA-FITC) (clone
CB9, 1:100) and IFN-γ-PE-Cy7 (clone 4S.B3, 1:100) (both
BD Biosciences). To prevent non-specific binding via
Fc receptors, each well was supplemented with 5 μl
Pentaglobin. Finally cells were washed three times and
centrifuged for 3 min at 400 g. The data from flow cy-
tometric analyses were processed with FACS Diva soft-
ware v5.0.3. A well with cells stained with the above
mentioned antibodies except for IFN-γ-PE-Cy7 served
as control for the measurements of IFN-γ expression
by NK cells.
Conjugate-forming assay
After two days of culture and 24 h in vitro stimulation
with leptin (50 nM) or vehicle in R10 medium (contain-
ing 10% FCS, 100 U/ml penicillin, 100 μg/ml strepto-
mycin) cell surface staining of the PBMCs (5 × 105 cells/
100 μl) was performed in 96-well round-bottom plates
by adding CD3-PE (1:250) and CD56-APC (1:100) and
incubating for 15 min at 4°C. After two washes and a
centrifugation (400 g for 3 min), each well was supple-
mented with 1×106/ml cells of the K562 erythroleukemia
line (which were maintained in suspension culture flasks
at 37°C in a humidified atmosphere with 5% CO2). Cells
were centrifuged at 100 g for 3 min at 4°C and incubated
for 15 min at 37°C, 5% CO2 and 85% RH. Cells were
carefully resuspended and transferred into FACS tubes
using pipet tips with expanded apertures. After gently
mixing the cells, conjugate formation was analyzed using
a FACSCanto (BD Biosciences) by gating on PBMC and
K562 cells, excluding CD3+ T cells.
Proliferation assay
PBMCs (0.5 × 106 cells / 250 μl) were incubated with
CFSE (Carboxy Fluorescein Succinimidyl Ester; final con-
centration 1.5 μM) for 7 min at 37°C in a cell incubator.Cells were resuspended in 250 μl of R10 culture medium
(1 × 106/ml) including IL-2 (0.001%) and leptin (50 nM)
or vehicle and incubated for 7 days. Medium was re-
freshed on day 4. After 7 days of culture cell surface stain-
ing of PBMCs (5 × 105 cells/100 μl) was performed in
96-well round-bottom plates by adding CD3-PE (1:250)
and CD56-APC (1:100) and incubating for 15 min at
4°C. Cells were washed twice with measuring buffer
and analyzed by flow cytometry using a FACSCanto
(BD Biosciences) with FACS Diva software v5.0.3. The
percentage of proliferating cells was determined as the
number of gated NK cells that displayed a distinctively
lesser fluorescence.
Western blotting
PBMCs were stained in wells with 1,000,000 cells per
well. Negative controls were incubated with PBS whereas
the samples were stimulated with 50 nM leptin for 5 and
15 min at 37°C. Stimulated PBMCs were collected on
ice, centrifuged (500 g, 3 min, 4°C) and supernatants
were removed. Afterwards, the pellets were resuspended
in PBS, re-centrifuged and supernatants removed. The
pellets were lysed in RIPA buffer (50 mM Tris, pH 7.5,
150 mM NaCl, 0.5% sodium deoxycholate, 1% Nonidet
P-40, and 0.1% SDS) containing protease inhibitor
(Complete Mini; Roche, Mannheim, Germany), 1 mM
sodium orthovanadate, 50 mM NaF, and 200 μg/l oka-
daic acid for 10 min on ice and stored at −80°C.
Protein concentrations of samples were determined
via photometry by Olympus AU400 (Olympus). Equal
amounts of protein samples were denatured in 15 μl
Laemmli buffer (containing 5% beta mercaptoethanol
of total volume; Bio-Rad Laboratories, Hercules, CA)
and heated at 95°C for 10 min. The samples were loa-
ded (7 μg per lane) into a NuPAGE 4-12% Bis-Tris gel
(Invitrogen, Carlsbad, CA), resolved in sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto nitrocellulose membranes with a
pore size of 0.2 μm (SERVA Electrophoresis, Heidelberg,
Germany).
The membranes were blocked with 5% nonfat milk
in Tris-buffered saline (50 mM TrisHCl, pH 7.4 and
150 mM NaCl) containing 0.1% Tween-20 (TBS-T) at
room temperature for 60 min on a shaking table, fol-
lowed by an overnight incubation with primary an-
tibodies in 5% BSA/TBS-T at 4°C on a shaking table.
Primary antibodies were anti-phospho-Jak2 (Tyr1007/
1008) (dilution 1:1250; New England Biolabs, Frankfurt,
Germany) and anti-beta-actin (dilution 1:1250; Sigma-
Aldrich, St. Louise, MO). Membranes were rinsed three
times (5 min each) with TBS-T, followed by an incuba-
tion with horseradish peroxidase-conjugated secondary
antibody (dilution 1:3000; New England Biolabs) for
60 min at room temperature. The peroxidase activity
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standard enhanced chemiluminescence (ECL plus;
Amersham, GE Healthcare, Freiburg, Germany) pro-
cedure. Quantitative analysis of the Western blots of 3
normal weight and 3 obese individuals was performed
using ImageJ 1.48v (http://rsb.info.nih.gov/ij). Values
were normalized to actin.
Statistics
Data are expressed as means + SEM. P-values of less then
0.05 were considered significant. The software used was
GraphPad Prism 4 (GraphPad Software Inc.). Results were
analyzed using one-way ANOVA with the factor ‘body
weight’ or ‘stimulation’. If overall effects showed signifi-
cant differences / interactions Tukey multiple comparison
test for post hoc analysis was implemented.
Results
BMI and clinical characteristics
In total, 20 subjects were investigated in the study
(normal weight: 4 females, 4 males; obese: 3 females,
9 males). No significant differences between the two
groups (normal weight and obese) in age and height
were found (Table 1). However, the two groups signifi-
cantly differed in the weight (mean body weight of
70.0 kg vs. 121.6 kg; p < 0.0001) resulting in a signifi-
cant BMI difference of 22.2 kg/m2 vs. 38.5 kg/m2 (p <
0.0001). From 10 subjects (normal weight: 5; obese: 5)
triglycerides, cholesterol and glucose levels were deter-
mined. Concerning triglycerides, cholesterol and glu-
cose levels no significant difference could be detected
between normal weight and obese subjects.
NK cell numbers
In both groups approximately 11% of all lymphocytes
were NK cells (Figure 1A). NK cells can be divided in
CD56dim and CD56bright by the expression of CD56 [25].Table 1 Baseline characteristics of study population
Normal weight Obese
(mean ± SEM) (mean ± S
Age (years) 39.3 ± 6.4 47.5 ± 3.9
Height (m) 1.77 ± 0.04 1.78 ± 0.03
Weight (kg) 70.0 ± 4.2 121.6 ± 5.3
BMI (kg/m2) 22.2 ± 0.6 38.5 ± 0.8
Triglycerides§ 1.0 ± 0.3 1.8 ± 0.4
Cholesterol§ 4.4 ± 0.4 4.3 ± 0.3
Glucose§ 4.3 ± 0.3 5.2 ± 0.3
SEM = standard error of the mean.
BMI = body mass index.
n.a. = not applicable.
§ = measured for 5 normal weight and 5 obese individuals.CD56dim NK cells express the surface antigen in low
concentration and have the capability to form conjugates
with target cells whereas the CD56bright NK cells pre-
dominantly produce pro-inflammatory cytokines, e.g.
TNF-α and IFN-γ. No significant difference between
normal weight and obese concerning the expression of
CD56dim and CD56bright was found (Figure 1B-D).
CD3+CD56+ cells
CD3+CD56+ cells have structural similarities with NK
cells (CD56; NK1.1) and T cells (CD3; αβ T cell re-
ceptors) [26] and are activated by lipid-based antigens
presented by CD1d [27]. Obese individuals showed sig-
nificantly lower amounts of CD3+CD56+ cells as com-
pared to the normal weight controls (Figure 1E). No
distinct difference concerning the T cell numbers from
obese and normal weight subjects could be observed
(Figure 1F).
Components of the Ob-R signaling pathway
We determined the Ob-R expression on peripheral blood
NK cells with flow cytometry and observed slightly more
Ob-R+ NK cells in obese subjects (Figure 2A). There are
six alternatively spliced Ob-R isoforms sharing the same
extracellular domain but only the long form, Ob-Rb, is
capable of signal transduction [28]. To evaluate the signal
transduction via Ob-Rb we determined the phosphoryl-
ation of JAK2 in isolated PBMCs after in vitro stimulation
with leptin for 5 and 15 min by Western blotting. Lower
levels of p-JAK2, a downstream target of the intracellular
signaling cascade of the Ob-Rb receptor, were detected
PBMCs in obese subjects (Figure 2B).
TRAIL, CD107a and CD178 expression by NK cells
To evaluate differences in the activity of human NK cells
in obese and normal weight subjects we measured the



































































Figure 1 Leukocyte subsets in healthy normal weight and obese subject. Isolated PBMCs from healthy normal weight and obese subjects
were stained with antibodies and analyzed by flow cytometry. (A) NK (CD56+CD3−) cells as percentage of lymphocytes; (B) CD56bright cells and
(C) CD56dim cells as percentage of NK cells. (D) Representative flow cytometry dot plots of CD56bright and CD56dim cells from a normal weight
individual; insert in the dot plot show the prior gaiting for NK cells (CD56+CD3−) in the upper left quadrant. (E) CD3+CD56+ cells as percentage of
lymphocytes; (F) T (CD3+CD56−) cells as percentage of lymphocytes. Data are expressed as mean + SEM. Significant effects of obese vs. normal
weight subjects are indicated by an asterisk *p < 0.05.
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bound TRAIL is well-known as one effector mechan-
ism of NK cells to induce apoptosis [29,30]. Compared
to normal weight subjects the TRAIL positive NK cells
were significantly lower in the obese (Figure 3A). No
difference between normal weight and obese subjects
could be observed concerning the number of CD178
(Fas ligand; a crucial promoter for programmed cell death
by apoptosis; [31,32]) expressing NK cells (Figure 3B).
The number of NK cells expressing CD107a, another
marker of NK cell activity (e.g. for IFN-γ and TNF-α
cytokine production; [33]), were reduced by nearly 40%
in the obese subjects as compared to the lean controls
(Figure 3C).
Intracellular IFN-γ expression
To evaluate the influence of a leptin stimulation on dif-
ferent functional parameters, human NK cells were
stimulated with human recombinant leptin for 24 h.
Numbers of NK-cell-tumor-cell-conjugates as well as
Granzyme positive and IFN-γ positive NK cells were
determined by flow cytometry. Short-term leptin ad-
ministration resulted in slightly improved levels of NK-
cell-tumor-cell-conjugates as compared to the vehicle
treated controls both in normal weight and obese subjects(Figure 4A). NK cells induce cell death via Granzymes
released into target cells [34,35]. Leptin stimulation was
without effect on the numbers of Granzyme+ NK cells
(Figure 4B). However, the intracellular IFN-γ expres-
sion after leptin administration was significantly higher
in normal weight subjects as compared to the correspon-
ding normal weight controls (Figure 4C). No stimu-
lation effect could be seen in the NK cells from obese
subjects.NK cell proliferation after long-term leptin stimulation
To evaluate the proliferative capacity of control and
long-term (7 days in vitro) leptin stimulated NK cells in
normal weight and obese subjects levels of proliferating
NK cells were determined by flow cytometry. No sig-
nificant difference could be detected between numbers
of proliferating NK cells in obese subjects as compared
to corresponding normal weight (~60% of all NK cells;
Figure 5B). Long-term leptin stimulation resulted in a
non-significant higher amount of proliferating NK cells
in obese as compared to vehicle treated controls. Inter-
estingly, obese subjects showed a non-significant higher
amount of multiple proliferating NK cells as compared












Figure 2 Leptin receptor (Ob-R) expression and signaling pathway in PBMCs. PBMCs from healthy normal weight and obese subjects were
stained with antibodies and analyzed by flow cytometry; (A) Numbers of Ob-R positive NK cells are shown in percentage of NK cells. Data are
expressed as mean + SEM. Representative flow cytometry dot plots of ObR+ and ObR- NK cells from a normal weight (middle panel) and an
obese individual (right panel) are shown. (B) Isolated PBMCs from normal weight and obese individuals (shown with body mass index (BMI)) were
stimulated for 5 and 15 min with 50 nM human recombinant leptin. Phosphorylation of JAK2 (p-JAK2) was determined by Western blotting. Actin
was used as control for equal loading. The experiment was repeated with 3 normal weight and 3 obese individuals, and a representative Western
blot is shown. Quantitative analysis of the Western blots for p-JAK2. Values were normalized to actin and are shown as fold induction in arbitrary
units (AU). Data are expressed as mean + SEM. Significant effects of obese vs. normal weight subjects are indicated by an asterisk *p < 0.05.
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Excess bodyweight is associated with an increased risk of
malignancy, e.g. esophageal adenocarcinoma and colon
cancer [5,6]. However, the link between obesity and
cancer susceptibility is still elusive. Leptin is a hormone
secreted by adipocytes linking nutritional status with
neuroendocrine and immune functions. The impact of
leptin on human NK cells, part of the innate immune
system, especially of a short- and long-term leptin ex-
posure, needs to be further investigated.
In this study, we observed no difference of CD56bright
(expressed in high density on surface with activity in
producing cytokines) and CD56dim (expressed in low
density with focus on cytotoxic features) NK cells be-
tween obese and normal weight individuals. NKT cells
that have structural characteristics from NK as well
as T cells were found to have a role in tumor immunity
of mice without and following stimulation (such as
αGalCer or IL-12 [36]). The reported anti-metastatic
effect was dependent on IFN-γ production and NK cell
activation through NKT cells [37,38]. Our data present
significantly lower levels of NKT (CD3+CD56+) cells in
obese subjects supporting the impaired protective ac-
tivity due to obesity. Recent studies revealed type I and IINKT cells by different molecular markers [39]. Interes-
tingly, patients with obesity (BMI > 40) and cancer had
higher levels of type I NKT cells in the greater omen-
tum compared to a lean control group [27]. Furthermore,
clinical studies implied a correlation between type I NKT
cell counts and prognosis for several human cancer
types. By contrast, type II NKT cells were found to sup-
press anti-tumor immunity in several mouse models by
producing IL-13 [39].
Like human T lymphocytes [18] and murine mono-
cytes, NK cells express Ob-R. NK cells show increased
levels of activated STAT3 as well as transcripted IL-2
and Perforin genes following leptin stimulation through
Ob-Rb [20]. To evaluate the impact of endogenous high
elevated leptin levels in obese subjects on the Ob-R ex-
pression we determined Ob-R on peripheral blood NK
cells with flow cytometry. In obese subjects (with long-
term endogenous leptin exposure) non-significant higher
levels of Ob-R+ NK cells were found. However, we know
from former studies in diet-induced obese rats [24] and
human PBMCs [21] that Ob-R post receptor signaling is
altered. Therefore we evaluated downstream signaling
in response to an in vitro leptin challenge. Sanchez-
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Figure 3 Expression of functional parameters of NK cells. PBMCs were stained with antibodies and analyzed by flow cytometry to evaluate
the differences of functional parameters in normal weight and obese subjects. (A) TNF-related apoptosis-inducing ligand (TRAIL) positive NK cells,
(B) CD178 positive NK cells, and (C) CD107a positive NK cells as percentage of NK cells. Representative flow cytometry dot plots of CD107a from
a normal weight (middle panel) and an obese individual (right panel). Inserts in both dot plots show the prior gating for NK cells (CD56+CD3−) in
the upper left quadrant. Data are expressed as mean + SEM. Significant effects of obese vs. normal weight subjects are indicated by an
asterisk *p < 0.05.
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tion [38]. Post receptor signaling of Ob-R revealed lower
levels in phosphorylation of JAK2 in PBMCs after leptin
administration as compared to PBMCs of normal weight
subjects confirming our data from previous studies.
Beside cytokine secretion, NK cells can induce apop-
tosis. TRAIL belongs to the TNF superfamily with its
death receptor pathway for apoptosis. After stimulation
with IFN-γ NK cells express TRAIL [30]. TRAIL isFigure 4 Effects of a leptin stimulation on NK-cell-tumor-cell-conjuga
PBMCs from healthy normal weight and obese subjects were stimulated w
Thereafter, cells were stained with antibodies and analyzed by flow cytome
mia line), (B) Granzyme positive NK, (C) IFN-γ positive NK cells are shown a
effects of leptin stimulated IFN-γ positive vs. non-stimulated NK cells in thecrucial for the IFN-γ dependent NK cell-derived protec-
tion from subcutaneous tumor growth as well as tumor
metastasis in mice [29,30]. Moreover, mice infected with
encephalomyocarditis virus showed earlier death after
administration of anti-TRAIL mAb [40]. Interestingly,
in vitro experiments showed that only inactivation of
Fas ligand, Perforin and TRAIL decreases NK cell cytotox-
icity against susceptible target cells [41]. With CD107a,
there is an additional marker of NK cell activity. It hastes and IFN-γ and Granzyme production of human NK cells.
ith 50 nM human recombinant leptin or treated with vehicle for 24 h.
try. (A) Numbers of NK-cell-tumor-cell-conjugates (K562 erythroleuke-
s percentage of NK cells. Data are expressed as mean + SEM. Significant
normal weight group are indicated by an asterisk *p < 0.05.
Figure 5 Effect of leptin stimulation on cell proliferation of human NK cells. PBMCs from healthy normal weight and obese subjects were
stimulated with 50 nM human recombinant leptin or vehicle for 7 days, stained with antibodies and analyzed with flow cytometry. (A)
Representative histograms of CSFE staining showing four proliferation peaks of NK cells from a normal weight (upper histogram) and an obese
(lower histogram) subjects. The peaks, from P4 (parental generation) to P1, represent successive generations. (B) Numbers of proliferating NK cells
as percentage of NK cells. Data are expressed as mean + SEM.
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in vitro with lysis of target cells as well as cytokine pro-
duction [33,42].
Here we present significantly higher levels of TRAIL+
NK cells in obese subjects. In contrast to expectations,
the expression of CD178 and CD107a on NK cells re-
vealed no difference between normal weight and obese
individuals.
To further explain the discrepancy of normal OB-R+
NK cell counts and lower levels of p-JAK2 we investi-
gated several NK cell activity parameters following lep-
tin challenge. Wrann et al. showed diminished NK cell
immune functions (such as IFN-γ secretion) after long-
term incubation (72 h) with leptin. In contrast, short-
term leptin stimulation revealed significantly higher
functions of human NK cells [21] as well as in human NK
cell lymphoma cell lines YT and NK-92 [20]. Takeda et al.
demonstrated, that IFN-γ is essential for the suppression
of subcutaneous tumor growth through TRAIL. Here we
show comparable numbers of IFN-γ+ NK cells in normal
weight and obese subjects. The amount of IFN-γ+ NKcells in normal weight subjects was significantly higher
following short-term leptin challenge, whereas no effect
was seen in the obese. This is in line with demonstrations
of Wrann et al.: only short-term incubation (18 h) in-
creased IFN-γ production of NK cells [21] and points to-
wards a higher activity of innate immunity in normal
weight individuals.
Beside cytotoxic activity, proliferation of NK cells is
crucial for immune responses. In the present study, we
observed no difference in the proliferation rate of hu-
man NK cells in both investigated groups. Interestingly,
obese subjects had a non-significant higher amount of
multiple proliferating NK cells as compared to normal
weight subjects, suggesting a modified proliferation pro-
cess in the obese.
Further studies with isolated NK cells and co-cultures
with tumor cells are required to investigate the contri-
bution of leptin and other adipocytokines on NK cell
functions. Furthermore, other receptor pathways remain
major goals to understand increased cancer susceptibility
in obesity.
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The present study demonstrates significant lower TRAIL
and p-JAK2 expression in NK cells from obese healthy
humans. Chronically elevated endogenous leptin levels
may be one mechanism for NK cell dysfunctions and con-
secutive increased cancer susceptibility in obese humans.
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